Warby Parker Inc. WRBY
21.29 USD -0.65 (-2.96%)
At closeNov 5, 2026, 8:27 AM EST
25.69 +4.40 +20.67%
Pre-market · Nov 5, 8:27 AM ET
21.20 Day range 23.90
14.96 52-week range 31.00
- YTD
- -2.29%
- 1 year
- +11.76%
- Market cap
- 2.63B
- Revenue (ttm)
- 911.61M
- Profit margin
- 0.85%
- EPS (ttm)
- 0.06
- Shares out
- 108.24M
- P/E ratio
- 354.83
- Forward P/E
- 34.61
- YTD return
- -2.29%
- 1-year return
- +11.76%
- Volume
- 8.62M
- Avg volume
- 3.02M
- Open
- 23.25
- Previous close
- 21.94
- Day's range
- 21.20 – 23.90
- 52-week range
- 14.96 – 31.00
- Beta
- 1.95
- Analysts
- Buy
- Price target
- 31.00 (+45.6%)
- Earnings date
- Nov 5, 2026
2Y +2.86 (+15.53%)
Key statistics
- Enterprise value
- 2.67B
- PEG ratio
- 0.00
- Price / sales
- 2.88
- Price / book
- 6.70
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 9.80%
- Free cash flow
- 9.53M
- Total cash
- 292.67M
- Total debt
- 250.98M
- Return on equity
- 2.06%
- Short % of float
- 23.58%
- 50-day average
- 24.98
- 200-day average
- 25.11
Analyst view
Consensus: buy
Buy
Price target (mean) 31.00 +45.6% upside
Now 21.29
- Target (low)
- 25.00
- Target (mean)
- 31.00
- Target (high)
- 35.00
Ratings (0m) 13 10 buy · 3 hold · 0 sell
- Strong buy2
- Buy8
- Hold3
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.09255.
Financials — quick view
WRBY Revenue — quarterly 235.51M
WRBY Net income — quarterly 4.64M
WRBY EPS — quarterly 0.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.09385 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.1017 | 0.13 | +0.03 | +27.83% |
| May 7, 2026 | Mar 31, 2026 | 0.11 | 0.12 | +0.01 | +9.09% |
| Feb 26, 2026 | Dec 31, 2025 | 0.05 | 0.01884 | -0.03 | -62.32% |
| Nov 6, 2025 | Sep 30, 2025 | 0.09 | 0.11 | +0.02 | +22.22% |
| Aug 7, 2025 | Jun 30, 2025 | 0.08 | 0.08 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | UBS | main | Neutral | Neutral |
| Aug 7, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Jun 29, 2026 | B of A Securities | init | — | Buy |
| May 8, 2026 | UBS | main | Neutral | Neutral |
| May 7, 2026 | BTIG | main | Buy | Buy |
| Mar 17, 2026 | Citigroup | main | Neutral | Neutral |
About Warby Parker Inc.
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- warbyparker.com
News
Warby Parker Raises FY2026 Sales Guidance from $959.000M-$976.000M to $966.000M-$976.000M vs $969.200M Est 
Warby Parker Announces Third Quarter 2026 Results 
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Warby Parker Reports Q2 2026 Results: Full Earnings Call Transcript
CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday 
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session 
UBS Maintains Neutral on Warby Parker, Raises Price Target to $28 
Citizens Maintains Market Outperform on Warby Parker, Lowers Price Target to $29 
Warby Parker Affirms FY2026 Sales Guidance of $959.000M-$976.000M vs $979.991M Est 
CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday
Your note
Sign in to keep a note on WRBY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLUMENTHAL NEIL HARRIS | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 1, 2026 | 440,406 |
| BRIGGS TERESA | Director | Sale | Jun 15, 2026 | 64,852 |
| CUTLER JOEL E | Director | Stock Gift | Dec 15, 2025 | 0 |
| GILBOA DAVID ABRAHAM | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 1, 2026 | 40,406 |
| HUNT ANDREW | Director | Stock Award(Grant) | Jun 7, 2026 | 1,941,240 |
| MILLER STEVEN CLIVE | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 2, 2025 | 233,123 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.39% | 15,577,440 | 331.41M | Jun 29, 2026 |
| Blackrock Inc. | 14.14% | 15,309,616 | 325.71M | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 10.27% | 11,110,949 | 236.39M | Jun 29, 2026 |
| Durable Capital Partners Lp | 5.91% | 6,396,513 | 136.09M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.53% | 5,983,328 | 127.30M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.15% | 4,487,337 | 95.47M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.66% | 6,121,596 | 130.24M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 4.26% | 4,605,777 | 97.99M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.98% | 3,226,137 | 68.64M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.47% | 2,677,124 | 56.96M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.15% | 2,331,236 | 49.60M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 1.44% | 1,558,400 | 33.15M | Jun 29, 2026 |